SGN-17/19

A substance composed of a monoclonal antibody-enzyme fusion protein (SGN-17), containing a cloned binding region of the L49 monoclonal antibody and the enzyme beta-lactamase, and an inactive prodrug form of Mephalan (SGN-19) used in Antibody Directed Enzyme Therapy (ADEPT). (NCI Thesaurus)

YOU MAY ALSO LIKE

SGN-00101

A substance that is being studied in the prevention of cancer. It belongs to the family of drugs called fusion proteins. …

SGMS2 wt Allele

Human SGMS2 wild-type allele is located in the vicinity of 4q25 and is approximately 90 kb in length. This allele, which encodes…

SGMS2 Gene

This gene is involved in cell growth.

SGMS1 wt Allele

Human SGMS1 wild-type allele is located in the vicinity of 10q11.2 and is approximately 319 kb in length. This allele, which encodes…

SGMS1 Gene

This gene plays a role in phosphatidylcholine and ceramide metabolism.

SGLT2 Inhibitor

Any inhibitor of the sodium-glucose co-transporter subtype 2 (SGLT2) with antihyperglycemic activity. By binding to and blocking SGLT2, these inhibitors suppress reabsorption…